جست‌وجوی استاد و پژوهشگر

• Proteomics
• Mass Spectrometry
• Protein Biochemistry
• +۶ مورد دیگر

TuKiet Lam is a Research Scientist and Director of the Keck MS & Proteomics Resource at Yale School of Medicine's Department of Molecular Biophysics and Biochemistry. He holds joint leadership of the Discovery Proteomics Core of the Yale/NIDA Neuroproteomics Center and is affiliated with Yale Cancer Center's Cancer Signaling Networks Program. Dr. Lam's research focuses on advanced mass spectrometry applications in proteomics and metabolomics. Key areas include: Protein identification and quantitative profiling in complex biological systems Analysis of posttranslational modifications (phosphorylation, ubiquitination, palmitoylation) Biomarker discovery for neurological disorders and cancers Development of novel mass spectrometry workflows His work spans diverse samples including brain tissue, cerebrospinal fluid, extracellular vesicles, and clinical specimens. Recent publications demonstrate strong research output in neurodegeneration (Alzheimer's, Parkinson's), oncology (glioblastoma), and substance use disorders. Common themes include subcellular proteomics, extracellular vesicle characterization, and multi-omic approaches integrating proteomic data with transcriptomic and clinical findings. Dr. Lam leads the Keck MS & Proteomics Resource, which provides: High-resolution tandem mass spectrometry services Protein identification and quantification Posttranslational modification analysis Targeted metabolomics The facility supports numerous NIH-funded projects and is equipped with Orbitrap mass spectrometers maintained through NIH S10 grants.

• Hair follicle development
• Regeneration
• Dermal niche
• +۷ مورد دیگر

Peggy Myung, MD, PhD is Vice Chair of Research and Associate Professor of Dermatology and Pathology at Yale School of Medicine. She maintains strong affiliations across multiple Yale entities including the Yale Cancer Center, Yale Stem Cell Center, Cancer Signaling Networks Program, and Pathology Research Program in Translational Biomedicine. Dr. Myung leads the Myung Lab which focuses on hair follicle development and regeneration research, with applications to understanding skin cancer mechanisms. Dr. Myung received her MD and PhD from the University of Pennsylvania in 2003, completed residencies at Hospital of the University of Pennsylvania and University Hospitals Case Medical Center, and a fellowship at Yale University School of Medicine in 2014. She is board certified in both Dermatology (2012) and Dermatopathology (2014, with recertification in 2025). Her research program investigates how heterotypic signals between the skin epidermis and dermis regulate robust and organized hair follicle growth during embryonic development and adult regeneration. The Myung Lab specifically examines: (1) how cellular behaviors such as cell divisions and movement are regulated by key morphogenetic signals during regeneration, (2) how these signals are spatially disseminated to ensure robust but patterned growth, and (3) how these mechanisms contribute to disorganized growth during tumorigenesis. The hair follicle serves as an ideal model for these studies due to its accessibility and well-characterized cyclical regeneration dependent on resident stem cells. Dr. Myung's recent publication record demonstrates consistent productivity in high-impact journals, with a growing emphasis on single-cell genomic techniques and computational approaches to understand cellular interactions at unprecedented resolution. Her work bridges developmental biology, dermatology, and cancer research, with particular focus on Wnt/β-catenin signaling and epithelial-mmesenchymal interactions. Dr. Myung has received notable recognition including: $30K Biotech Accelerator Award (June 2023) Yale Medicine 'Top Doctor' listing (2024) As Vice Chair of Research, Dr. Myung oversees research initiatives within the Department of Dermatology while maintaining an active laboratory program that combines multi-photon imaging, quantitative RNA fluorescent in situ hybridization, single-cell RNA/ATAC sequencing, and in vivo mouse genetic models. Her long-term goal is to develop novel treatments for hair loss and to prevent and treat non-melanoma skin cancer by applying knowledge of hair morphogenetic signals to suppress aberrant growth in carcinogenesis.

• Magnetic Resonance Imaging
• Advanced Image Reconstruction
• Quantitative MRI Methods
• +۵ مورد دیگر

Tobias Wood serves as a Senior Lecturer in Magnetic Resonance Imaging within Neuroimaging, leading multiple externally funded research initiatives focused on advancing quantitative MRI methodologies. His primary institutional affiliation remains implied through project leadership but is not explicitly stated in available documentation. Research interests span the full spectrum of Magnetic Resonance Imaging with particular emphasis on advanced image reconstruction techniques and quantitative biomarker development . His work bridges engineering innovation with clinical applications in neurological disorders including multiple sclerosis, Parkinson's disease, and Huntington's disease, while also exploring novel frontiers like the neurocutaneous axis in inflammatory skin conditions. The research fingerprint reveals strong concentration in Myelin Imaging (49%), In Vivo Neuroscience (32%), and Parkinson's Disease research (31%). Recent publications demonstrate consistent output in high-impact journals including Magnetic Resonance in Medicine and Neuropsychopharmacology , with emerging focus on ultra-low-field MRI applications and multi-modal biomarker validation. Key trends include methodological innovation in silent scanning protocols, pediatric coil development, and translation of quantitative techniques to clinical monitoring. Current funding portfolio includes five major projects totaling approximately £2.5M, with leadership roles in EPSRC and CHDI Foundation grants. Collaborative networks span 11 similar research profiles with strong connections to multiple sclerosis research, neurodegenerative disorders, and advanced imaging physics communities. Lab resources include access to high-field MRI systems, specialized computational infrastructure, and clinical validation partnerships. Supervision approach emphasizes interdisciplinary training with strong publication expectations and industry-academic career pathways.

Eike Nagelمشاهده پروفایل

استاد

• Cardiovascular Imaging
• Cardiology
• Magnetic Resonance Imaging
• +۶ مورد دیگر

Eike Nagel serves as DZHK Professor for Cardiology and Director of the DZHK Centre for Cardiovascular Imaging at Goethe University Hospital Frankfurt. He leads the Institute for Experimental and Translational Cardiovascular Imaging (Goethe CVI) within the Medical Faculty and holds dual appointments as Consultant Cardiologist in Cardiology and Radiology departments. A founding member and Past President of the Society for Cardiovascular Magnetic Resonance (SCMR), his career spans over 25 years of pioneering CMR research with 500+ publications. Research Focus: Prof. Nagel specializes in translational cardiovascular imaging biomarkers for coronary artery disease, cardiomyopathy, and heart failure (HF-REF/HFpEF). His work develops and validates clinical CMR techniques including stress perfusion MRI (adenosine/regadenoson), dobutamine stress MRI, and quantitative tissue mapping (T1/T2/ECV) to characterize myocardial pathology and improve diagnostic pathways. Current investigations target myocardial fingerprinting for HFpEF classification and biomarker qualification. Publication Impact: His recent research demonstrates leadership in standardizing CMR protocols and validating tissue characterization biomarkers. Key trends include myocardial tissue quantification for coronary disease prognosis, mapping techniques for early sarcoidosis detection, and multi-center consensus on imaging endpoints – all driving clinical implementation of quantitative CMR. Scientific Recognition: Gold Medal of the Society for Cardiovascular Magnetic Resonance (SCMR) (2016) Training & Research Leadership: Prof. Nagel directs Goethe CVI's Clinical Trial Unit supporting non-commercial studies (e.g., MR-INFORM, Decipher-HFpEF) as imaging core lab. He mentors through international CMR fellowships for clinicians, physicists, and radiographers, emphasizing standardized acquisition and interpretation protocols. Institutional Role: The Goethe CVI Institute under his leadership integrates experimental research with clinical service, focusing on imaging standardization to personalize cardiovascular treatment. Current initiatives include IMPReSSION Study for myocardial inflammation and Distr@l platform for distributed CMR analysis.

Atiyah Yahyaمشاهده پروفایل

دانشیار

• Magnetic Resonance Spectroscopy
• In-vivo Metabolite Quantification
• Lipid MRS
• +۶ مورد دیگر

Atiyah Yahya, Ph.D., FCCPM, P.Eng., FCOMP is an Associate Professor in the Division of Medical Physics within the Department of Oncology at the University of Alberta's Faculty of Medicine & Dentistry. He serves as Senior Medical Physicist at the Cross Cancer Institute's Department of Medical Physics, conducting research using 3T and 9.4T MRI scanners. Education: Ph.D. in Medical Sciences (Biomedical Engineering and Electrical/Computer Engineering), University of Alberta B.Sc. in Engineering Physics, University of Alberta Yahya's research focuses on in-vivo magnetic resonance spectroscopy (MRS) with emphasis on lipid and brain metabolite quantification. His work develops advanced MRS techniques for measuring cancer-relevant metabolites, particularly improving proton MRS quantification of lipids and applying MRS to monitor treatment responses. His laboratory utilizes both 3T and 9.4T MRI systems at the Cross Cancer Institute for technical development and clinical applications. Analysis of his 15 most recent publications reveals a consistent focus on MRS methodology refinement (80% of works), particularly PRESS/STEAM sequence optimization for metabolite separation at high fields. Key technical themes include J-coupling effects (47% of papers), lipid composition analysis (33%), and neurotransmitter quantification (20%). His research bridges physics innovation with clinical oncology applications, with 60% of recent work directly addressing cancer metabolism. Scientific Awards: Fellow of the Canadian College of Physicists in Medicine (FCCPM) Professional Engineer (P.Eng.) - APEGA Fellow of the Canadian Organization of Medical Physicists (FCOMP) CCPM Certification in Diagnostic Radiological Physics and MRI Physics Yahya directs the Medical Physics Imaging Residency Program and coordinates multiple graduate courses including Oncol 556 (Laboratory in Imaging) and Oncol 691 (Advanced Magnetic Resonance Physics). His teaching portfolio spans diagnostic radiology physics (MEDPH 468/ONCOL 568), advanced MRI methods (ONCOL 690), and research seminars (ONCOL 600). While specific grant details aren't provided, his extensive publication record in high-impact journals suggests significant research funding support. His laboratory operates within the Cross Cancer Institute's imaging facilities, leveraging the institute's 3T and 9.4T MRI platforms for both technical development and clinical translation of MRS techniques.

• Magnetic Resonance Imaging
• Biomedical Imaging
• Medical Physics
• +۵ مورد دیگر

Prof. Dr. Jens Frahm is a Research Group Leader at the Max Planck Institute for Multidisciplinary Sciences in Göttingen, Germany, where he heads the Biomedical NMR research group. He has led this group since 1982 and completed his habilitation at the University of Göttingen in 1994. Dr. Frahm's research focuses on the development and application of magnetic resonance imaging techniques. His work combines methodological advances with biomedical and clinical research to harness MRI's potential for characterizing living tissue. His team has pioneered real-time MRI technologies that enable visualization of dynamic physiological processes including joint movements, speech articulation, swallowing, and cardiac function without requiring breath-holds or ECG gating. Frahm's research has dramatically transformed clinical MRI practice. His FLASH (Fast Low Angle Shot) technology, invented in 1985, reduced MRI acquisition times by a factor of 100, making modern clinical MRI feasible. In 2010, his team developed FLASH 2, enabling image acquisition in as little as 10-40 milliseconds per frame, allowing for true real-time MRI of physiological processes. His scientific achievements have been recognized with numerous prestigious awards: Grand Cross of Merit of the Federal Republic of Germany (2025) European Inventor Award (2018) Werner von Siemens Ring (2020) Gold Medal Award of the International Society for Magnetic Resonance in Medicine (1991) Induction into the German Science Hall of Fame (2016) Frahm's FLASH technology is estimated to be used in approximately 100 million MRI examinations worldwide each year. Nearly every MRI scanner in hospitals globally utilizes his patented technology, which remains one of the Max Planck Society's most successful patents. His current research focuses on further developing real-time MRI for whole-body screening applications and monitoring minimally invasive procedures in real time. His laboratory continues to work on mathematical methods for image reconstruction that require minimal measurements per image, enabling observation of dynamic physiological processes in living organisms. The team maintains strong collaborations with clinical partners to translate these technological advances into medical practice.

Arpiar Saundersمشاهده پروفایل

استادیار

• single-cell genomics
• host-virus interactions
• neural circuits
• +۲ مورد دیگر

Arpiar Saunders is an Assistant Professor at the Vollum Institute, Oregon Health & Science University, leading research on neural circuit organization through innovative genomic approaches. His work bridges neuroscience, virology, and computational biology to decode synaptic wiring principles. His educational background includes: B.A. in Biology and Linguistics from Swarthmore College (2006) Ph.D. in Neuroscience from Harvard Medical School (2014) Dr. Saunders' research focuses on developing single-cell and single-virion genomic technologies to map synaptic connections and investigate host-virus interactions in neural tissue. His lab pioneers methods like viral barcoding to correlate molecular profiles with circuit architecture, addressing how genetic variation impacts brain connectivity in psychiatric disorders. Key interests span synaptic biology, neural diversity, and comparative circuit evolution. His publication record reveals a strong interdisciplinary trajectory, integrating genomics and virology to advance neural mapping. Recent work emphasizes quantitative reconstruction of synaptic relationships from RNA-seq data and characterization of cell-type-specific wiring. Major recognitions include: Helen Hay Whitney Postdoctoral Fellowship (2016–19) NIH F31 Predoctoral Fellowship (2011–14) Harvard's Richard J. Herrnstein Dissertation Award (2014) As principal investigator of the Saunders Lab, he directs a team developing cutting-edge genomic tools to dissect neural circuit organization, with ongoing projects examining virus-brain interactions and synaptic vulnerability in disease contexts.

Maren Schrölkampمشاهده پروفایل

پژوهشگر

• Molecular Cardiology
• Membrane Proteins
• Cardiovascular Genetics
• +۴ مورد دیگر

Maren Schrölkamp is an Academic employee with an MSc in Biochemistry at the Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen. She is affiliated with the Molecular Cardiology and Membrane Proteins research group and maintains an active research profile with publications in high-impact journals such as Nature Communications, European Heart Journal, and Frontiers in Cell and Developmental Biology. Her ORCID profile (0000-0003-3522-6379) documents her scholarly contributions to biomedical research. Her research interests span multiple interconnected domains in biomedical sciences, with primary focus on Molecular Cardiology and Membrane Proteins . Her work explores cardiovascular genetics, proteomics of cardiac tissues, adipose stem cell biology in obesity, and epigenetic mechanisms in metabolic disorders. She has contributed to understanding the molecular basis of conditions including mitral valve prolapse, diabetes in pregnancy, and narcolepsy. Her research methodology frequently employs advanced techniques such as quantitative proteomics, transcriptomics, and genome-wide association studies. Analysis of her seven recent publications reveals a strong emphasis on molecular mechanisms underlying cardiovascular diseases, with growing interest in genetic and epigenetic factors. Her work shows increasing collaboration with international research teams, particularly evident in her 2022 European Heart Journal publication with 34 additional authors. The research spans basic science investigations of cellular mechanisms to clinical applications in cardiovascular genetics and metabolic disorders. Maren Schrölkamp has no publicly listed scientific awards in the provided information. Her research has been disseminated through multiple peer-reviewed publications with significant citation impact, including 84 citations for her Nature Communications paper on cardiac pacemaking mechanisms. While specific grant information is not provided in the text, her collaborative publications suggest participation in multi-institutional research projects. The diversity of her research topics indicates involvement in multiple research initiatives across cardiovascular biology, metabolic disorders, and sleep medicine. She is actively affiliated with the Molecular Cardiology and Membrane Proteins research group at the University of Copenhagen's Department of Biomedical Sciences. This research environment focuses on understanding the molecular mechanisms of cardiovascular function and disease, utilizing advanced proteomic and genomic techniques to investigate cardiac biology at the cellular and molecular levels.

• Endoscopic ultrasound
• Endobronchial ultrasound
• Gastroenterology
• +۶ مورد دیگر

Peter Vilmann is a Clinical Professor at the Department of Clinical Medicine, University of Copenhagen, where he has been a Full Professor of Endoscopy at Copenhagen University Hospital Herlev since 2010. He leads an Excellence Center for EUS (Endoscopic Ultrasound) and CLE (Confocal Laser Endomicroscopy) in Europe, which became operational in September 2012. His academic journey includes training at various Danish hospitals (1982-1993), positions at Herlev Hospital and Rigshospitalet, and a long tenure at Gentofte Hospital where he served as Overlæge (1995-2009) and Scientific Lecturer (2005-2010). MD (cand.med), University of Copenhagen (1981) Specialization in Gastroenterology (1994) and Surgery (1993), University of Copenhagen MD.Sc (dr.med A-disputats), University of Copenhagen (1998) Honoris Causa, University of Medicine and Pharmacy Craiova, Romania (2011) Professor Vilmann pioneered EUS with linear transducers and was the first in the world to perform EUS-guided fine needle biopsy (1991). His research focuses on advanced endoscopic techniques including EUS, EBUS, NOTES, CLE, and EUS-guided therapeutic interventions. He has made significant contributions to EUS-FNA procedures, EUS-guided pseudocyst drainage, bile duct drainage, and non-anesthesiologist propofol sedation (NAPS) programs. His work bridges diagnostic and therapeutic applications in gastrointestinal endoscopy with particular emphasis on pancreatic and biliary interventions. His recent publications (2023-2025) demonstrate continued innovation in pancreatic tumor ablation, virtual reality for colonoscopy training, advanced sedation techniques, and the integration of EUS with novel imaging technologies. The research consistently focuses on improving diagnostic accuracy, procedural safety, and developing minimally invasive alternatives to surgery for gastrointestinal conditions. Scientific Recognition: The Swedish Society of Medicine Jubileumspriset (1999) Copenhagen county employee Idea Prize (2005) Doctor Honoris Causa from University of Medicine and Pharmacy Craiova, Romania (2009) Primary Doctors at Gentofte Hospital Honorary award (2011) Visiting Professorship in Chandigarh, India (2011) Herlev Hospitals High Impact prize (2011) Professor Vilmann has secured substantial research funding including grants from The A.P. Møller and Chastine Mc-Kinney Møller Foundation ($387,045), Arvid Nilssons Foundation ($324,875), Toyota Foundation ($63,170), The Jochum Foundation ($90,243), and Aase and Ejnar Danielsen Foundation ($27,073). He serves on editorial boards for several prestigious journals including Endoscopy and Endoscopic Ultrasound, and has been instrumental in developing guidelines through the European Society of Gastrointestinal Endoscopy (ESGE) Guideline Committee. His endoscopy center at Herlev Hospital functions as a clinical and translational research environment with state-of-the-art equipment for EUS and CLE. The center supports numerous international multicentric studies including research on EUS-guided gallbladder drainage, needle-based CLE for pancreatic masses, and characterization of Crohn's disease using CLE technology.

• NMR Spectroscopy
• Food Quality Analysis
• Metabolomics
• +۴ مورد دیگر

Nanna Viereck serves as an Associate Professor in the Department of Food Science at the University of Copenhagen's Faculty of Science, specializing in Food Analytics and Biotechnology within the Spectroscopy & Chemometrics section. She has held this position since 2009 and additionally serves as vice-manager of her section and Deputy Head of Research for the Department since 2014. Her academic journey includes an Assistant Professor role from 2003-2009, a postdoctoral position at Risø National Laboratory (2002-2003), and a brief research visit to Adelaide University (2003). PhD in Life Sciences and Chemistry, Roskilde University (2002) MSc in Laboratory of Molecular Spectroscopy, University of Copenhagen (1997) Nanna's research centers on NMR spectroscopy applications in food science, with expertise in both liquid and solid state low and high field NMR for food systems analysis and metabolomics. She has developed quantitative NMR methods for food quality screening using multivariate data analysis approaches. Her work spans diverse food matrices including pectins/alginates, carbohydrates, lipids, and whole foods like dairy products, cereals, and beverages. She has contributed significantly to the Department's metabolomics platform development and conducts research on NMR studies of biological tissues and biofluids. Analysis of her publication record reveals consistent contributions to food science and analytical chemistry, with particular emphasis on NMR spectroscopy applications. Her work shows progression from fundamental NMR methodology development to applied food quality and metabolomics research, with increasing interdisciplinary collaboration across nutrition, plant science, and dairy technology fields. Nanna actively supervises students, having guided 10 MSc students since 2004 and co-supervised 2 PhD students since 2008. She has secured research funding reflected in her 42 research outputs including journal articles, book chapters, and conference presentations, with an H-index of 9 as of 2015. She has organized significant conferences including the innovation conference 'Fødevareingredienser – et dansk væksteventyr' (2013) and co-chaired the annual inSPIReFOOD conference (2013-2014). As a member of Biopeople's Food & Health working party and manager of the inSPIRe pillar for process analytical technology, she maintains strong connections between academic research and industry applications. Her leadership extends to course development, including Quantitative Bio-spectroscopy and Food Entrepreneurship courses taught in collaboration with DTU.

Huseyin GUNERمشاهده پروفایل

مدرس

• Bioinformatics
• Computational Biology
• Proteomics
• +۷ مورد دیگر

Huseyin GUNER is a Lecturer in the Department of Molecular Biology and Genetics at Abdullah Gül University in Kayseri, Turkey. With a strong background spanning physics, computer science, and molecular biology, he bridges computational approaches with biological research to tackle complex scientific questions. His educational journey includes: PhD Candidate in Computer Engineering at Abdullah Gül University (2019-2022) Bachelor's degree in Physics from Middle East Technical University (1991-1997) Prior to his current position, GUNER worked as a Bioinformatician at the University of Wisconsin-Madison (2008-2015) in the Human Proteomics Program and Mass Spectrometry Facility. His research expertise spans bioinformatics, computational biology, proteomics, and mass spectrometry, with significant contributions to software development for proteome analysis including MASH Suite Pro and the recently developed BrAIn system for brain organoid analysis. His interdisciplinary approach integrates artificial intelligence with molecular biology to address challenges in drug discovery, cancer biology, neuroscience, and stem cell research. Analysis of GUNER's publication record reveals a consistent focus on developing and applying computational methods to biological problems. His work demonstrates expertise in both theoretical algorithm development and practical experimental validation. Recent publications show increasing emphasis on AI applications in neuroscience and continued contributions to proteomics methodology. His research has practical implications for drug discovery, disease modeling, and diagnostic tool development, particularly in areas like inflammatory bowel disease treatment, multiple sclerosis therapy, and cancer immunotherapy. GUNER has published 27 scientific articles that have garnered 9,253 reads and 817 citations, indicating substantial impact in his research areas. His collaborative network spans multiple disciplines and institutions including Johns Hopkins Medicine, Izmir International Biomedicine and Genome Institute, and University of Wisconsin-Madison. As a lecturer, GUNER contributes to academic training in molecular biology and genetics while maintaining an active research program. His unique background in physics, computer science, and molecular biology enables him to approach complex biological problems from multiple perspectives, fostering innovative solutions at the intersection of computational and experimental biology.